Grundläggande statistik
| CIK | 1564273 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Immage Biotherapeutics Corp.
SEC Filings (Chronological Order)
Denna sida innehåller en komplett, kronologisk lista över SEC-arkiveringar, exklusive ägande-arkiveringar som vi tillhandahåller på andra ställen.
| June 21, 2017 |
15-15D 1 immg1515d.htm 15-15D OMB APPROVAL OMB Number: 3235-0167 Expires: March 31, 2018 Estimated average burden hours per response….1.50 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) |
|
| April 19, 2017 |
IMMG / Immage Biotherapeutics Corp. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended February 28, 2017 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to 333-185368 Commission File Number IMMAGE BIOTHERAPEUTI |
|
| April 17, 2017 |
Immage Biotherapeutics NT 10-Q immgnt10q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: October 31, 2018 Estimated average burden hours per response ..............2.50 SEC FILE NUMBER: 333-185368 CUSIP NUMBER: 45250J 100 (Check One): ? Form 10-K ? Form 20-F ? Form 11-K x Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CS |
|
| February 28, 2017 |
immg8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 16, 2017 Date of Report (Date of earliest event reported) IMMAGE BIOTHERAPEUTICS CORP. (Exact name of registrant as specified in its charter) Nevada 333-185368 68-0682040 (State or other jurisdiction of incorporat |
|
| January 6, 2017 |
Immage Biotherapeutics FORM 10-Q (Quarterly Report) immg10q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2016 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to 333-185368 Commission File Number IMMAGE B |
|
| December 8, 2016 |
Immage Biotherapeutics FORM 10-K (Annual Report) immg10k.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended August 31, 2016 o TRANSITION REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 333-185368 IMMAGE BIOTHERAPEUTICS CORP. (Name of small business issuer as specifi |
|
| November 29, 2016 |
Immage Biotherapeutics NT 10-K immgnt10k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: October 31, 2018 Estimated average burden hours per response ..............2.50 SEC FILE NUMBER: 333-185368 CUSIP NUMBER: 45250J 100 (Check One): - X Form 10-K Form 20-F Form 11-K Form 10-Q Form 10-D Form N-SAR Form N-CSR For Peri |
|
| July 15, 2016 |
Immage Biotherapeutics FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 31, 2016 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to 333-185368 Commission File Number IMMAGE BIOTHERAPEUTICS CO |
|
| April 14, 2016 |
Immage Biotherapeutics FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended February 29, 2016 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to 333-183797 Commission File Number IMMAGE BIOTHERAP |
|
| January 19, 2016 |
IMMG / Immage Biotherapeutics Corp. 10-Q - Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2015 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to 333-183797 Commission File Number IMMAGE BIOTHERAP |
|
| January 14, 2016 |
Immage Biotherapeutics FORM 12B-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: October 31, 2018 Estimated average burden hours per response ..............2.50 SEC FILE NUMBER: 333-157618 CUSIP NUMBER: 45307L 108 ( Check One): - Form 10-K Form 20-F Form 11-K X Form 10-Q Form 10-D Form N-SAR Form N-CSR For Period Ended: Nov |
|
| September 10, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Immage Biotherapeutics Corp. (Exact Name of Small Business Issuer in its Charter) Date of Report (Date of earliest event reported): September 8, 2015 Nevada 8731 68-0682040 (State of Incorporation) (Primary Standard Classification Code) (IRS Employer ID No.) 10411 Motor City Drive Bethesda, MD 20817 (Address of Regist |
|
| September 10, 2015 |
Revised Article VII of the Company Bylaws. EXHIBIT 3.1 ARTICLE VII-FISCAL YEAR The fiscal year of the Corporation shall be fixed, and shall be subject to be change by the Board of Directors from time to time, subject to applicable law. The fiscal year of the Corporation shall be August 31. |
|
| August 14, 2015 |
Immage Biotherapeutics FORM 12B-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number: 333-185368 (Check one) [ ] Form 10-K [ ] Form 11-K [ ] Form 20-F [X ] Form 10-Q [ ] Form N-SAR For Period Ended: June 30, 2015 [ ] Transition Report on Form 10-K and Form 10-KSB [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition R |
|
| August 6, 2015 |
Exhibit 16.1 PLS CPA, A PROFESSIONAL CORPORATION 4725 MERCURY STREET #210 SAN DIEGO CALIFORNIA 92111 TELEPHONE (858)722-5953 FAX (858) 761-0341 FAX (858) 764-5480 E-MAIL [email protected] August 4, 2015 Securities and Exchange Commission 100 F Street, NE Washington, DC 20549-7561 Re: Immage Biotherapeutics Corp. Dear Madame or Sir On August 3, 2015 our appointment as auditor for Immage Biothera |
|
| August 6, 2015 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Immage Biotherapeutics Corp. (Exact Name of Small Business Issuer in its Charter) Date of Report (Date of earliest event reported): July 10, 2015 Nevada (State of Incorporation) 8731 (Primary Standard Classification Code) 68-0682040 (IRS Employer ID No.) 10411 Motor City Dr., Bethesda, MD 20817 (Address of Registrant' |
|
| July 29, 2015 |
Memorandum of Understanding by and between the Company and Howard University, dated July 10, 2015. EX-10.2 3 ex-102.htm EX-10.2 Exhibit 10.2 |
|
| July 29, 2015 |
Executive Employment Agreement with Mahesh Narayanan, dated July 15, 2015. Exhibit 10.3 |
|
| July 29, 2015 |
Asset Purchase Agreement by and between the Company and Papvax, Inc., dated June 4, 2015. Exhibit 10.1 |
|
| July 29, 2015 |
Executive Employment Agreement with Daniel Achinko, dated July 15, 2015. Exhibit 10.6 |
|
| July 29, 2015 |
Executive Employment Agreement with Elton Norman, dated July 15, 2015. EX-10.4 5 ex-104.htm EX-10.4 Exhibit 10.4 |
|
| July 29, 2015 |
Executive Employment Agreement with Anton Dormer, dated July 15, 2015. Exhibit 10.5 |
|
| July 29, 2015 |
Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Immage Biotherapeutics Corp. (Exact Name of Small Business Issuer in its Charter) Date of Report (Date of earliest event reported): July 28, 2015 Nevada (State of Incorporation) 8731 (Primary Standard Classification Code) 68-0682040 (IRS Employer ID No.) 10411 Motor City Dr., Bethesda, MD 20817 (Address of Registrant' |
|
| June 18, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 10, 2015 Date of Report (Date of earliest event reported) IMMAGE BIOTHERAPEUTICS CORP. (Exact name of registrant as specified in its charter) Nevada 333-183797 68-0682040 (State or other jurisdiction of incorporation) (Commissio |
|
| May 15, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 11, 2015 Date of Report (Date of earliest event reported) EPICURE CHARCOAL INC. (Exact name of registrant as specified in its charter) Nevada 333-183797 68-0682040 (State or other jurisdiction of incorporation) (Commission File N |
|
| December 29, 2014 |
IMMG / Immage Biotherapeutics Corp. NT 10-K - - NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): x Form 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: September 30, 2014 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition Report |
|
| November 13, 2014 |
EXHIBIT 16.1 Kenne Ruan, CPA, P.C. Phone: (203) 824-0441 Fax: (203) 413-6486 40 Hemlock Hollow Road, Woodbridge, CT 06525 Email: [email protected] November 10, 2014 Office of the Chief Accountant Securities and Exchange Commission 100F Street, NE Washington, D.C. 20549 Dear Sir/Madam: We have read the statements made by Epicure Charcoal, Inc (the Company), which were provided to us and which we u |
|
| November 13, 2014 |
Changes in Registrant's Certifying Accountant 8-K 1 epic8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: November 5, 2014 Epicure Charcoal, Inc. (Exact name of registrant as specified in its charter) Nevada 333-185368 45-5538945 (State or other jurisdiction of incorporation) (Commission File Num |
|
| October 3, 2014 |
IMMG / Immage Biotherapeutics Corp. DEF 14C - - DEF 14C SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ¨ Preliminary Information Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) x Definitive Information Statement Epicure Charcoal, Inc. (Name of Registrant as Specified In Its |
|
| May 15, 2014 |
NOTIFICATION OF LATE FILING (Check One): o Form 10-K and o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: March 31, 2014 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Transition Report on Form N-SAR For the Transition Period Ended: Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. |
|
| March 5, 2014 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: x Preliminary Information Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) o Definitive Information Statement Epicure Charcoal, Inc. (Name of Registrant as Specified In Its |
|
| February 14, 2014 |
Immage Biotherapeutics FORM 10-Q (Quarterly Report) epic10q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2013 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to 333-185368 Commission File Number EPICU |
|
| July 29, 2013 |
July 29, 2013 Era Anagnosti Securities and Exchange Commission Washington D.C. 20549 Re: Epicure Charcoal, Inc. Request for Acceleration of effective Date of Registration Amendment No 3 to Registration Statement on Form S-1 Filed July 01, 2013 File No, 333-185368 Dear Ms. Anagnosti, We hereby request that the Commission accelerate the effective date of our registration statement filed with the Com |
|
| July 1, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A (Amendment No. 3) REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 EPICURE CHARCOAL, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organization) 2990 (Primary Standard Industrial Classification Code Number) 45-5538945 (I.R.S. Employer Ident |
|
| July 1, 2013 |
July 1, 2013 Era Anagnosti Securities and Exchange Commission Washington D.C. 20549 Re: Epicure Charcoal, Inc. Registration Statement on Form S-1 Filed June 3, 2013 File No, 333-185368 Dear Ms. Anagnosti In response to your letter dated June 25, 2013 the following information, corresponding sequentially to the paragraphs in your letter, is hereby submitted on behalf of Epicure Charcoal, Inc. (the |
|
| June 3, 2013 |
May 31, 2013 Era Anagnosti Securities and Exchange Commission Washington D.C. 20549 Re: Epicure Charcoal, Inc. Registration Statement on Form S-1 Filed February 8, 2013 File No, 333-185368 Dear Ms. Anagnosti In response to your letter dated February 20, 2013 the following information, corresponding sequentially to the paragraphs in your letter, is hereby submitted on behalf of Epicure Charcoal, In |
|
| June 3, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A (Amendment No. 2) REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 EPICURE CHARCOAL, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organization) 2990 (Primary Standard Industrial Classification Code Number) 45-5538945 (I.R.S. Employer Ident |
|
| February 8, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A (Amendment No. 1) REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 EPICURE CHARCOAL, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organization) 2990 (Primary Standard Industrial Classification Code Number) 45-5538945 (I.R.S. Employer Ident |
|
| February 8, 2013 |
February 8, 2013 Era Anagnosti Securities and Exchange Commission Washington D.C. 20549 Re: Epicure Charcoal, Inc. Registration Statement on Form S-1 Filed December 10, 2012 File No, 333-185368 Dear Ms. Anagnosti In response to your letter dated January 3, 2013 the following information, corresponding sequentially to the paragraphs in your letter, is hereby submitted on behalf of Epicure Charcoal, |
|
| December 10, 2012 |
EXHIBIT 3.2 |
|
| December 10, 2012 |
Registration Statement - FORM S-1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 EPICURE CHARCOAL, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation or organization) 2090 (Primary Standard Industrial Classification Code Number) 45-5538945 (I.R.S. Employer Identification Number) 69 |
|
| December 10, 2012 |
SUBSCRIPTION AGREEMENT EPICURE CHARCOAL, INC. 112 North Curry Street Carson City Nevada, 89703 EXHIBIT 10.4 SUBSCRIPTION AGREEMENT EPICURE CHARCOAL, INC. 112 North Curry Street Carson City Nevada, 89703 A. Instructions. Each person considering subscribing for the Shares should review the following instructions: Subscription Agreement: Please complete, execute and deliver to the Company the enclosed copy of the Subscription Agreement. The Company will review the materials and, if the subscri |
|
| December 10, 2012 |
EXHIBIT 3.1 1 2 Page 2 |
